MétaCan
Menu
Back to cohort

HUMAN ENT1 IS PREDICTIVE OF RESPONSE IN PATIENTS WITH PANCREATIC CANCER TREATED WITH GEMCITABINE

2007· article· en· W2065488194 on OpenAlexaff
James J. Farrell, Montse García, Raymond Lai, Ali Ammar, William F. Regine, Ross A. Abrams, Al B. Benson, J. S. Macdonald, Carol E. Cass, Hany Elsaleh, John R. Mackey

Bibliographic record

VenuePancreas · 2007
Typearticle
Languageen
FieldMedicine
TopicPancreatic and Hepatic Oncology Research
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsMedicineGemcitabineInternal medicineOncologyStainingImmunohistochemistryProportional hazards modelPancreatic cancerMultivariate analysisGastroenterologyPathologyCancer

Abstract

fetched live from OpenAlex

Background: Human equilibrative nucleoside transporter (hENT1) is responsible for gemcitabine transport into cells. Small retrospective studies in pancreatic cancer suggest that hENT1 tumor levels may have prognostic and predictive value. We studied hENT 1 protein expression in a cohort of pancreatic adenocarcinoma patients from the RTOG 9704: a large prospective randomized adjuvant treatment trial. Methods: RTOG 9704 randomized 538 patients after surgical resection to treatment containing either 5-FU or gemcitabine. A tissue microarray was constructed using three separate cores from 225 resected pancreatic tumors from RTOG 9704. HENT1 Immunohistochemistry was performed and scored as having no staining, low staining or high staining (>50% cells positive) Associations between hENT1 protein expression, either dichotomized (no staining vs. low and high staining) or ungrouped (no staining vs. low vs high staining) with tumor demographic details and treatment outcome (overall survival and disease free survival), were analyzed by unconditional logistic regression analysis using the Chi-square test and the Cox proportional hazards model. Both treatment arms of the study were analyzed. Results: Of the 538 patients entered into RTOG 9704, 198 from both arms of the study were eligible and had analyzable hENT1. hENT1 expression was not associated with overall or disease-free survival in a univariate or multivariate model when evaluating patients treated with 5-FU alone and comparing the dichotomized hENT1 level variable (No staining vs. Low, High (>50%) and the ungrouped hENT1 level variable (No staining, Low and High (>50%).Of the 268 patients entered on the Gemcitabine arm, 91 were eligible and had analyzable hENT1. Univariate and multivariate analyses for hENT1 is shown in Table 1 (expressed as hazard ratio (HR) (95% confidence intervals).TABLE 1: hENT1 and Survival in Pancreatic Adenocarcinoma treated with GemcitabineConclusion: In this prospective randomized trial, hENT1 protein expression is associated with a statistically significant improvement in overall survival and disease free survival in pancreatic cancer patients receiving gemcitabine, but not in those not receiving gemcitabine. This prospective data suggests that hENT1, a gemcitabine transporter, is a useful mechanistic predictive marker of response to gemcitabine in patients with pancreatic cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.025
Threshold uncertainty score0.636

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.321
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2007
Admission routes1
Has abstractyes

Explore more

Same venuePancreasSame topicPancreatic and Hepatic Oncology ResearchFrench-language works237,207